Tavio Capital LLC - Q3 2019 holdings

$189 Million is the total value of Tavio Capital LLC's 11 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 125.0% .

 Value Shares↓ Weighting
LH BuyLABORATORY CORP AMER HLDGS$32,914,000
+6.7%
195,916
+9.8%
17.40%
+39.0%
MCK BuyMCKESSON CORP$25,351,000
+25.3%
185,502
+23.2%
13.40%
+63.1%
HCA BuyHCA HEALTHCARE INC$17,260,000
+7.9%
143,333
+21.1%
9.12%
+40.5%
HUM NewHUMANA INC$15,822,00061,885
+100.0%
8.36%
PDCO BuyPATTERSON COMPANIES INC$11,608,000
-0.6%
651,397
+27.7%
6.14%
+29.4%
BSX NewBOSTON SCIENTIFIC CORP$6,691,000164,433
+100.0%
3.54%
WMGI NewWRIGHT MED GROUP N V$6,676,000323,625
+100.0%
3.53%
PRAH NewPRA HEALTH SCIENCES INC$4,769,00048,063
+100.0%
2.52%
CI NewCIGNA CORP NEW$4,706,00031,004
+100.0%
2.49%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC13Q2 202029.6%
CENTENE CORP DEL11Q2 202019.1%
ANTHEM INC10Q2 201922.5%
BOSTON SCIENTIFIC CORP9Q4 201920.9%
RETROPHIN INC9Q1 20193.4%
ZIMMER BIOMET HOLDINGS INC8Q2 202020.6%
HUMANA INC8Q4 201937.8%
UNIVERSAL HLTH SVCS INC8Q1 201914.7%
HCA HEALTHCARE INC8Q1 202012.3%
MCKESSON CORP7Q2 202023.1%

View Tavio Capital LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2020-10-01
13F-HR2020-08-13
13F-HR2020-05-14
13F-HR2020-02-13
13F-HR2019-11-13
13F-HR2019-08-13
13F-HR2019-05-14
13F-HR2019-02-14
13F-HR2018-11-13
13F-HR2018-08-13

View Tavio Capital LLC's complete filings history.

Compare quarters

Export Tavio Capital LLC's holdings